Imolopesim

Dimeticone and Loperamide Hydrochloride, the active ingredients in Imolopesim, are antidiarrheal agents presented as an oral tablet for oral use. They are indicated for the relief of acute diarrhea, travel‑related diarrhea, and abdominal discomfort associated with gas in adults and children when appropriate.

GNH USA supplies Imolopesim as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imolopesim is an antidiarrheal combination that targets intestinal motility and gas formation.

Acute diarrhea: reduces stool frequency and improves stool consistency. Travel‑related diarrhea: provides rapid symptom control for travelers. Abdominal discomfort associated with gas: alleviates bloating and cramping caused by excess intestinal gas.

Imolopesim may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Constipation: reduced bowel movements. - Abdominal cramps: mild to moderate discomfort. - Nausea: feeling of queasiness. - Flatulence: increased gas. - Dry mouth: reduced salivation. - Dizziness: light‑headed sensation.

Serious or Rare Side Effects: - Severe constipation or bowel obstruction: persistent lack of stool passage. - Toxic megacolon: extreme dilation of the colon. - Cardiac arrhythmias: irregular heart rhythm. - Allergic reactions: rash, itching, swelling, or difficulty breathing. - Central nervous system depression: marked drowsiness or confusion. - Hepatotoxicity: abnormal liver function tests.

Before using Imolopesim, consider the following safety measures.

Avoid use in patients with known hypersensitivity to loperamide or dimeticone: discontinue if allergic reaction occurs. Do not exceed recommended duration in acute diarrhea without medical advice: risk of constipation. Caution in patients with severe hepatic impairment: monitor for accumulation. Use with care in children under 12 years: dosage and safety not established. Pregnancy and breastfeeding: consult healthcare professional before use. Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Imolopesim can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase loperamide levels. - CNS depressants (e.g., opioids, benzodiazepines): heightened risk of respiratory depression. - Anticholinergic agents: may exacerbate constipation.

Moderate Interactions (Monitor Closely): - Antidiarrheal agents (e.g., bismuth subsalicylate): additive effect on gut motility. - Antifungal azoles (e.g., fluconazole): modest increase in loperamide exposure. - Diuretics: monitor electrolyte balance if severe diarrhea resolves rapidly.